|
Volumn 2, Issue 4, 2003, Pages 375-377
|
Adalimumab (HUMIRA): a review.
a
a
11C
*
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
MONOCLONAL ANTIBODY;
BIOAVAILABILITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
HUMAN;
PSORIASIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RHEUMATOID ARTHRITIS;
SUBCUTANEOUS DRUG ADMINISTRATION;
ANTIBODIES, MONOCLONAL;
ARTHRITIS, RHEUMATOID;
BIOLOGICAL AVAILABILITY;
HUMANS;
INJECTIONS, SUBCUTANEOUS;
PSORIASIS;
RANDOMIZED CONTROLLED TRIALS;
|
EID: 0042570265
PISSN: 15459616
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (76)
|
References (19)
|